| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.013 | 0.9 |